Advancing medical research through contact center expertise and innovation

Carenet, a Stericycle division, reports a surge in patient recruitment for clinical studies related to oncology and cardiovascular health. This enhances consistently strong performance in patient recruitment, retention and compliance in a wide range of therapeutic areas.

An industry leader in contact center and communications solutions for the pharmaceutical, biopharmaceutical, medical device, food and beverage and government industries, Carenet is now leading the way in clinical trial patient recruitment for prostate and other cancers. Carenet is employing traditional contact center channels and new media, including SMS text and mobile strategies, for complex international trials. Health trained call center agents provide 24/7 best in class customer care in over twenty languages.

Carenet also reports a surge in cardiovascular-related health studies, with innovations that extend the ability to reach wider audiences in record time. Bringing a tradition of cardiovascular expertise to these trials, the Carenet contact center is able to communicate at a high level of professionalism to consumers and health professionals alike.

“We are proud to have effectively joined our health expertise to new technologies, enabling us to reach this level of excellence in patient recruitment in the fields of oncology, cardiovascular health, and many other therapeutic areas,” says Director of Contact Center and Online Operations Donald Houghton. “We value our position as industry leaders in patient recruitment and a range of issues related to consumer affairs, REMS, and drug and product safety.”

As health communications and services grow increasingly international and mobile, Carenet is at the forefront of industry trends, providing value through medical, technological, and international expertise.

Comments are closed.